Bentelan is one of 2 small molecule programs targeting Adenovirus Infection. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
1 competitor in Adenovirus Infection
Bentelan
Cytotoxic T-Lymphocytes
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details